EMEA (Europe, Middle East and Africa) Influenza Drugs Market Report 2019

Table of Contents

EMEA (Europe, Middle East and Africa) Influenza Drugs Market Report 2017
1 Influenza Drugs Overview
1.1 Product Overview and Scope of Influenza Drugs
1.2 Classification of Influenza Drugs
1.2.1 EMEA Influenza Drugs Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Influenza Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Zanamivir
1.2.4 Oseltamivir Phosphate
1.2.5 Peramivir
1.2.6 Other Influenza Drugs
1.3 EMEA Influenza Drugs Market by Application/End Users
1.3.1 EMEA Influenza Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Adults
1.3.3 Chidren
1.4 EMEA Influenza Drugs Market by Region
1.4.1 EMEA Influenza Drugs Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Influenza Drugs (2012-2022)
1.5.1 EMEA Influenza Drugs Sales and Growth Rate (2012-2022)
1.5.2 EMEA Influenza Drugs Revenue and Growth Rate (2012-2022)

2 EMEA Influenza Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Influenza Drugs Market Competition by Players/Manufacturers
2.1.1 EMEA Influenza Drugs Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Influenza Drugs Revenue and Share by Players (2012-2017)
2.1.3 EMEA Influenza Drugs Sale Price by Players (2012-2017)
2.2 EMEA Influenza Drugs (Volume and Value) by Type/Product Category
2.2.1 EMEA Influenza Drugs Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Influenza Drugs Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Influenza Drugs Sale Price by Type (2012-2017)
2.3 EMEA Influenza Drugs (Volume) by Application
2.4 EMEA Influenza Drugs (Volume and Value) by Region
2.4.1 EMEA Influenza Drugs Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Influenza Drugs Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Influenza Drugs Sales Price by Region (2012-2017)

3 Europe Influenza Drugs (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Influenza Drugs Sales and Value (2012-2017)
3.1.1 Europe Influenza Drugs Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Influenza Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Influenza Drugs Sales and Market Share by Type
3.3 Europe Influenza Drugs Sales and Market Share by Application
3.4 Europe Influenza Drugs Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Influenza Drugs Sales Volume by Countries (2012-2017)
3.4.2 Europe Influenza Drugs Revenue by Countries (2012-2017)
3.4.3 Germany Influenza Drugs Sales and Growth Rate (2012-2017)
3.4.4 France Influenza Drugs Sales and Growth Rate (2012-2017)
3.4.5 UK Influenza Drugs Sales and Growth Rate (2012-2017)
3.4.6 Russia Influenza Drugs Sales and Growth Rate (2012-2017)
3.4.7 Italy Influenza Drugs Sales and Growth Rate (2012-2017)
3.4.8 Benelux Influenza Drugs Sales and Growth Rate (2012-2017)

4 Middle East Influenza Drugs (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Influenza Drugs Sales and Value (2012-2017)
4.1.1 Middle East Influenza Drugs Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Influenza Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Influenza Drugs Sales and Market Share by Type
4.3 Middle East Influenza Drugs Sales and Market Share by Application
4.4 Middle East Influenza Drugs Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Influenza Drugs Sales Volume by Countries (2012-2017)
4.4.2 Middle East Influenza Drugs Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Influenza Drugs Sales and Growth Rate (2012-2017)
4.4.4 Israel Influenza Drugs Sales and Growth Rate (2012-2017)
4.4.5 UAE Influenza Drugs Sales and Growth Rate (2012-2017)
4.4.6 Iran Influenza Drugs Sales and Growth Rate (2012-2017)

5 Africa Influenza Drugs (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Influenza Drugs Sales and Value (2012-2017)
5.1.1 Africa Influenza Drugs Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Influenza Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Influenza Drugs Sales and Market Share by Type
5.3 Africa Influenza Drugs Sales and Market Share by Application
5.4 Africa Influenza Drugs Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Influenza Drugs Sales Volume by Countries (2012-2017)
5.4.2 Africa Influenza Drugs Revenue by Countries (2012-2017)
5.4.3 South Africa Influenza Drugs Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Influenza Drugs Sales and Growth Rate (2012-2017)
5.4.5 Egypt Influenza Drugs Sales and Growth Rate (2012-2017)
5.4.6 Algeria Influenza Drugs Sales and Growth Rate (2012-2017)

6 EMEA Influenza Drugs Manufacturers/Players Profiles and Sales Data
6.1 Bristol-Myers Squibb]
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Influenza Drugs Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Bristol-Myers Squibb] Influenza Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 AstraZeneca
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Influenza Drugs Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 AstraZeneca Influenza Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Eli Lilly
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Influenza Drugs Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Eli Lilly Influenza Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Roche
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Influenza Drugs Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Roche Influenza Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 GlaxoSmithKline
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Influenza Drugs Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 GlaxoSmithKline Influenza Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Novartis
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Influenza Drugs Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Novartis Influenza Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Pfizer
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Influenza Drugs Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Pfizer Influenza Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Sanofi Pasteur
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Influenza Drugs Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Sanofi Pasteur Influenza Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Bayer
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Influenza Drugs Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Bayer Influenza Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Celgene
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Influenza Drugs Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Celgene Influenza Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Seqirus
6.12 Protein Sciences Corporation
6.13 Serum Institute of India
6.14 Emergent Biosolutions
6.15 BioCryst Pharmaceuticals
6.16 Alvogen

7 Influenza Drugs Manufacturing Cost Analysis
7.1 Influenza Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Influenza Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Influenza Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Influenza Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Influenza Drugs Market Forecast (2017-2022)
11.1 EMEA Influenza Drugs Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Influenza Drugs Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Influenza Drugs Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Influenza Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Influenza Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Influenza Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Influenza Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Influenza Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Influenza Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Influenza Drugs Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Influenza Drugs
Figure EMEA Influenza Drugs Sales Volume (K MT) by Type (2012-2022)
Figure EMEA Influenza Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Zanamivir Product Picture
Figure Oseltamivir Phosphate Product Picture
Figure Peramivir Product Picture
Figure Other Influenza Drugs Product Picture
Figure EMEA Influenza Drugs Sales Volume (K MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Influenza Drugs by Application in 2016
Figure Adults Examples
Table Key Downstream Customer in Adults
Figure Chidren Examples
Table Key Downstream Customer in Chidren
Figure EMEA Influenza Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Influenza Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Influenza Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Influenza Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Influenza Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Influenza Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Influenza Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Influenza Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Influenza Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Influenza Drugs Market Major Players Product Sales Volume (K MT) (2012-2017)
Table EMEA Influenza Drugs Sales Volume (K MT) of Major Players (2012-2017)
Table EMEA Influenza Drugs Sales Share by Players (2012-2017)
Figure 2016 Influenza Drugs Sales Share by Players
Figure 2017 Influenza Drugs Sales Share by Players
Figure EMEA Influenza Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Influenza Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Influenza Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Influenza Drugs Revenue Share by Players
Table 2017 EMEA Influenza Drugs Revenue Share by Players
Table EMEA Influenza Drugs Sale Price (USD/MT) by Players (2012-2017)
Table EMEA Influenza Drugs Sales (K MT) and Market Share by Type (2012-2017)
Table EMEA Influenza Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Influenza Drugs by Type (2012-2017)
Figure EMEA Influenza Drugs Sales Market Share by Type (2012-2017)
Table EMEA Influenza Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Influenza Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Influenza Drugs by Type in 2016
Table EMEA Influenza Drugs Sale Price (USD/MT) by Type (2012-2017)
Table EMEA Influenza Drugs Sales (K MT) and Market Share by Application (2012-2017)
Table EMEA Influenza Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Influenza Drugs by Application (2012-2017)
Figure EMEA Influenza Drugs Sales Market Share by Application in 2016
Table EMEA Influenza Drugs Sales (K MT) and Market Share by Region (2012-2017)
Table EMEA Influenza Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Influenza Drugs by Region (2012-2017)
Figure EMEA Influenza Drugs Sales Market Share in 2016
Table EMEA Influenza Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Influenza Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Influenza Drugs by Region (2012-2017)
Figure EMEA Influenza Drugs Revenue Market Share Regions in 2016
Table EMEA Influenza Drugs Sales Price (USD/MT) by Region (2012-2017)
Figure Europe Influenza Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Europe Influenza Drugs Revenue and Growth Rate (2012-2017)
Table Europe Influenza Drugs Sales (K MT) by Type (2012-2017)
Table Europe Influenza Drugs Market Share by Type (2012-2017)
Figure Europe Influenza Drugs Market Share by Type in 2016
Table Europe Influenza Drugs Sales (K MT) by Application (2012-2017)
Table Europe Influenza Drugs Market Share by Application (2012-2017)
Figure Europe Influenza Drugs Market Share by Application in 2016
Table Europe Influenza Drugs Sales (K MT) by Countries (2012-2017)
Table Europe Influenza Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Influenza Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Influenza Drugs Sales Market Share by Countries in 2016
Table Europe Influenza Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Influenza Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Influenza Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Influenza Drugs Revenue Market Share by Countries in 2016
Figure Germany Influenza Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure France Influenza Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure UK Influenza Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Russia Influenza Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Italy Influenza Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Benelux Influenza Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Influenza Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Influenza Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Influenza Drugs Sales (K MT) by Type (2012-2017)
Table Middle East Influenza Drugs Market Share by Type (2012-2017)
Figure Middle East Influenza Drugs Market Share by Type (2012-2017)
Table Middle East Influenza Drugs Sales (K MT) by Applications (2012-2017)
Table Middle East Influenza Drugs Market Share by Applications (2012-2017)
Figure Middle East Influenza Drugs Sales Market Share by Application in 2016
Table Middle East Influenza Drugs Sales Volume (K MT) by Countries (2012-2017)
Table Middle East Influenza Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Influenza Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Influenza Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Influenza Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Influenza Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Influenza Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Influenza Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Israel Influenza Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure UAE Influenza Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Iran Influenza Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Influenza Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Influenza Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Influenza Drugs Sales (K MT) by Type (2012-2017)
Table Africa Influenza Drugs Sales Market Share by Type (2012-2017)
Figure Africa Influenza Drugs Sales Market Share by Type (2012-2017)
Figure Africa Influenza Drugs Sales Market Share by Type in 2016
Table Africa Influenza Drugs Sales (K MT) by Application (2012-2017)
Table Africa Influenza Drugs Sales Market Share by Application (2012-2017)
Figure Africa Influenza Drugs Sales Market Share by Application (2012-2017)
Table Africa Influenza Drugs Sales Volume (K MT) by Countries (2012-2017)
Table Africa Influenza Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Influenza Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Influenza Drugs Sales Market Share by Countries in 2016
Table Africa Influenza Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Influenza Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Influenza Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Influenza Drugs Revenue Market Share by Countries in 2016
Figure South Africa Influenza Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Nigeria Influenza Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Egypt Influenza Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Algeria Influenza Drugs Sales (K MT) and Growth Rate (2012-2017)
Table Bristol-Myers Squibb] Influenza Drugs Basic Information List
Table Bristol-Myers Squibb] Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb] Influenza Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Bristol-Myers Squibb] Influenza Drugs Sales Market Share in EMEA (2012-2017)
Figure Bristol-Myers Squibb] Influenza Drugs Revenue Market Share in EMEA (2012-2017)
Table AstraZeneca Influenza Drugs Basic Information List
Table AstraZeneca Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure AstraZeneca Influenza Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure AstraZeneca Influenza Drugs Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca Influenza Drugs Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly Influenza Drugs Basic Information List
Table Eli Lilly Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Eli Lilly Influenza Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Eli Lilly Influenza Drugs Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly Influenza Drugs Revenue Market Share in EMEA (2012-2017)
Table Roche Influenza Drugs Basic Information List
Table Roche Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Roche Influenza Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Roche Influenza Drugs Sales Market Share in EMEA (2012-2017)
Figure Roche Influenza Drugs Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline Influenza Drugs Basic Information List
Table GlaxoSmithKline Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Influenza Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Influenza Drugs Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Influenza Drugs Revenue Market Share in EMEA (2012-2017)
Table Novartis Influenza Drugs Basic Information List
Table Novartis Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis Influenza Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Novartis Influenza Drugs Sales Market Share in EMEA (2012-2017)
Figure Novartis Influenza Drugs Revenue Market Share in EMEA (2012-2017)
Table Pfizer Influenza Drugs Basic Information List
Table Pfizer Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Influenza Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Pfizer Influenza Drugs Sales Market Share in EMEA (2012-2017)
Figure Pfizer Influenza Drugs Revenue Market Share in EMEA (2012-2017)
Table Sanofi Pasteur Influenza Drugs Basic Information List
Table Sanofi Pasteur Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi Pasteur Influenza Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Sanofi Pasteur Influenza Drugs Sales Market Share in EMEA (2012-2017)
Figure Sanofi Pasteur Influenza Drugs Revenue Market Share in EMEA (2012-2017)
Table Bayer Influenza Drugs Basic Information List
Table Bayer Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bayer Influenza Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Bayer Influenza Drugs Sales Market Share in EMEA (2012-2017)
Figure Bayer Influenza Drugs Revenue Market Share in EMEA (2012-2017)
Table Celgene Influenza Drugs Basic Information List
Table Celgene Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Celgene Influenza Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Celgene Influenza Drugs Sales Market Share in EMEA (2012-2017)
Figure Celgene Influenza Drugs Revenue Market Share in EMEA (2012-2017)
Table Seqirus Influenza Drugs Basic Information List
Table Protein Sciences Corporation Influenza Drugs Basic Information List
Table Serum Institute of India Influenza Drugs Basic Information List
Table Emergent Biosolutions Influenza Drugs Basic Information List
Table BioCryst Pharmaceuticals Influenza Drugs Basic Information List
Table Alvogen Influenza Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Influenza Drugs
Figure Manufacturing Process Analysis of Influenza Drugs
Figure Influenza Drugs Industrial Chain Analysis
Table Raw Materials Sources of Influenza Drugs Major Manufacturers in 2016
Table Major Buyers of Influenza Drugs
Table Distributors/Traders List
Figure EMEA Influenza Drugs Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Influenza Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Influenza Drugs Price (USD/MT) and Trend Forecast (2017-2022)
Table EMEA Influenza Drugs Sales (K MT) Forecast by Region (2017-2022)
Figure EMEA Influenza Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Influenza Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Influenza Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Influenza Drugs Sales (K MT) Forecast by Countries (2017-2022)
Figure Europe Influenza Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Influenza Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Influenza Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Influenza Drugs Sales (K MT) Forecast by Countries (2017-2022)
Figure Middle East Influenza Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Influenza Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Influenza Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Influenza Drugs Sales (K MT) Forecast by Countries (2017-2022)
Figure Africa Influenza Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Influenza Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Influenza Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Influenza Drugs Sales (K MT) Forecast by Type (2017-2022)
Figure EMEA Influenza Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Influenza Drugs Sales (K MT) Forecast by Application (2017-2022)
Figure EMEA Influenza Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources